Mon, Feb 8, 2010
Oncology Product Research
Pre-
Clinical
IND
Filing
Phase
1
Phase
2
Phase
3
FDA
Appr-oval
Phase
4
GROWTH FACTOR BLOCKERS
Flt-3 MAb
INDICATION: AML, ALL
VEGFR-3 MAb
INDICATION: Solid tumors
VE-cadherin MAb
INDICATION: Solid tumors
FGFR MAb
INDICATION: Solid tumors
Ron MAb
INDICATION: Solid tumors
TRP-1 MAb
INDICATION: Solid tumors
PDGFRß MAb
INDICATION: Solid tumors
Neuropilin MAb
INDICATION: Solid tumors
Company Overview
|
Products
|
Product Support
|
Clinical Development
|
Research
|
Grant Requests
|
News
|
Careers
Copyright © 2009 ImClone LLC. All rights reserved.
